Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ereztech is a specialty chemical company that designs and manufactures high-purity organometallic and inorganic compounds. The company provides critical precursors and catalysts used in the semiconductor, advanced electronics, and life sciences industries. In the life sciences sector, Ereztech's products serve as essential reagents and catalysts for the synthesis of complex small molecule pharmaceuticals. Following its acquisition by SK Enpulse in 2024, Ereztech operates as part of the SK Group's advanced materials division. The company is recognized for its expertise in handling air-sensitive materials and providing custom synthesis services from laboratory to commercial scale.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ereztech.